Rothschild 2013.
Methods |
Parallel randomised controlled clinical trial (RCT) Randomisation ratio: 1:1 Superiority design |
|
Participants |
Inclusion criteria:
Exclusion criteria:
Diagnostic criteria: not stated Participating population: 144 Mexican Americans in the Chicago area |
|
Interventions |
Number of study centres: not stated Treatment before study: All participants were taking at least 1 oral hypoglycaemic agent. 35.4% were taking aspirin, and 46.5% were taking an ACEi or an ARB. The mean number of medications a patient was taking at baseline was 4.8 (SD = 2.9) The intervention included 36 visits over 2 years from a community health worker (from the same community), who delivered behavioural self‐management training using a curriculum derived from recommendations of the American Academy of Diabetes Educators (the AADE 7) |
|
Outcomes |
Primary outcomes:
Secondary outcomes:
|
|
Study details |
Run‐in period: recruitment of participants took place between January 2006 and September 2008 Study terminated before regular end: no |
|
Publication details |
Language of publication: English Funding: National Institute for Diabetes and Digestive and Kidney Diseases Publication status: peer‐reviewed journal |
|
Stated aim of study | To assess whether community health workers can improve glycaemic control among Mexican Americans with diabetes | |
Notes | — | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote from publication: "Randomisation used a permuted block design with block sizes of 4 and 6 in a single randomisation scheme. The Rush Preventive Medicine Data Management Center generated randomisation lists" |
Allocation concealment (selection bias) | Unclear risk | Comment: concealment method not described |
Blinding of participants and personnel (performance bias) Objective outcomes | High risk | Comment: participants and HCWs not blinded, which may artificially alter their performance in diabetic management |
Blinding of participants and personnel (performance bias) Subjective outcomes | High risk | Comment: participants and HCWs not blinded, which may artificially alter their performance in diabetic management |
Blinding of outcome assessment (detection bias) Lab tests: Lipids, HBA1C | Low risk | Comment: Research assistants blinded to participants’ group assignments collected outcome data at 12 and 24 months after randomisation |
Blinding of outcome assessment (detection bias) Subjective outcomes | High risk | Comment: Self‐reported subjective outcome measures are at high risk of bias given that participants were not blinded |
Incomplete outcome data (attrition bias) Objective outcomes | Unclear risk | Comment: data not available |
Incomplete outcome data (attrition bias) Subjective outcomes | Unclear risk | Comment: data not available |
Selective reporting (reporting bias) | Unclear risk | Comment: large quantity of baseline data collected, and follow‐up data not adequately provided. For instance, blood pressure is dichotomised as an outcome, whereas it is presented as continuous at baseline. Self‐efficacy is reported as "increasing significantly for both study arms," but no further details are provided |
Other bias | Unclear risk | Comment: none |